Tag: First Quarter (Q1)
Accendra Health reports Q1, announces $1.5B optimization
May 11, 2026HME News Staff
RICHMOND, Va. – Accendra Health reported $627.8 million for the first quarter of 2026 vs. $673.9 million for the same period last year. Adjusted EBITDA was $58.4 million vs. $96 million.
Unless otherwise noted, the results reflect Accendra’s continuing operations, which represent what was previously the Patient Direct segment and certain functional operations. The company ended the fourth quarter of 2025 by selling its Products & Healthcare Services (P&HS) business to Platinum...
Medline positions for sustained growth
May 11, 2026HME News Staff
NORTHFIELD, Ill. – Medline reported net sales of $7.4 billion for the first quarter of 2026, a 10.7% increase. Net income was $239 million, a 25.8% decrease.
Other financial results:
Adjusted EBITDA of $776 million, a decrease of 10.6%.
Diluted earnings per share and adjusted diluted EPS were $0.16 and $0.33, respectively.
Net cash provided by operating activities in the first quarter 2026 was $412 million, driven by net income, excluding the impact of non-cash items, partially...
Inogen credits ‘power of our strategy’
May 7, 2026HME News Staff
BEVERLY, Mass. - Inogen reported total revenue of $85.1 million for the first quarter of 2026, a 3.4% increase compared to the prior-year period, ahead of the company’s expectations.
Other financial results
Total gross margin was 44.5% in the first quarter of 2026 compared to 44.2% in the prior-year period. Adjusted gross margin improved by 30 basis points to 44.7% compared to 44.4% in the prior-year period due to cost improvements in the total cost of revenue.
GAAP net loss for...
AdaptHealth sets stage for ‘defining year’
May 5, 2026HME News Staff
CONSHOHOCKEN, Pa. – AdaptHealth reported revenue of $819.8 million for the first quarter ended March 31, 2026, an increase of 5.4% over the same period the prior year.
Other financial results
Organic revenue growth of 9.1%, with growth across each of the reportable Segments.
Net loss attributable to AdaptHealth Corp. was $16.0 million compared to net loss of $7.2 million.
Adjusted EBITDA was $121.2 million compared to $127.9 million, a decrease of 5.3%.
Cash flow from operations...
Resmed says it’s off to a strong start with 9% increase in revenue
October 30, 2025HME News Staff
SAN DIEGO – Resmed reported revenue of $1.9 billion for the first quarter of fiscal year 2026, a 9% increase compared to the same period in 2025.
“Our fiscal year 2026 is off to a strong start, with first-quarter performance reflecting continued progress toward our mission of helping people sleep better, breathe better and live longer and healthier, with care provided in their own home,” said Resmed’s Chairman and CEO Mick Farrell.
Other financial results:
Gross...
Inogen: ‘We feel we’re in a good position’
May 14, 2025Liz Beaulieu, Editor
GOLETA, Calif. – Given the company’s current exemptions, Inogen does not anticipate material impact on its operating plan or financial profile from announced tariffs.
Inogen, which recently announced a distribution agreement with Yuwell in China, believes it’s well positioned to continue executing on its strategic priorities despite these developments.
“However, the situation is dynamic, and we will continue to monitor it closely,” said Kevin Smith,...
InfuSystem positioned for ‘successful year’
May 12, 2025HME News Staff
ROCHESTER HILLS, Mich. - InfuSystem Holdings has reported net revenues of $34.7 million for the first quarter of 2025, a 9% increase compared to the same period last year. Of that, Patient Services net revenue was $20.8 million, a 12% increase, and Device Solutions was $13.9 million, a 4% increase. It reported net loss of $300,000 this year vs. $1.1 million last year. “I’m very pleased to report 2025 is off to an excellent start demonstrating solid growth,” said Richard Dilorio,...
AdaptHealth ‘stays the course’ for Q1
May 6, 2025HME News Staff
CONSHOHOCKEN, Pa. – AdaptHealth reported revenue of $777.9 million for the first quarter of 2025, a decrease of 1.8% compared to the same period last year.
Net loss attributable to AdaptHealth Corp. was $7.2 million compared to net loss of $2.1 million and adjusted EBITDA was $127.9 million compared to $158.5 million.
“Amid elevated uncertainty in the external environment, we at AdaptHealth have stayed the course, with a relentless focus on improving our business and...
Philips sees ‘encouraging start’ to year
May 6, 2025HME News Staff
AMSTERDAM – Philips has reported group sales of EUR 4.1 billion for the first quarter of 2025, a 2% decline, mainly due to China.
The company reported comparable order intake increased 2%, primarily driven by strong performance in North America, offsetting a decline in China, and income from operations increased to EUR 154 million. Adjusted EBITDA margin declined to 80 bps to 8.6% of sales.
“We remain dedicated to serving our customers, driving profitable growth and...
Henry Schein advances BOLD plan
May 5, 2025HME News Staff
MELVILLE, N.Y. - Henry Schein has reported total net sales of $3.2 billion for the first quarter 2025, with constant currency total net sales increasing 1.4% compared with the same period last year, and as-reported total net sales decreasing 0.1% due to a stronger U.S. dollar. Global Distribution and Value-Added Services sales increased 0.8% in constant currencies. Of that, Global Medical Distribution sales increased 3%, reflecting increased patient traffic to physician offices, strong growth in...